Harvest Management’s Cidara Therapeutics CDTX Stock Holding History

Harvest Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-52,500	Closed	-$11.6M	–	63
2025 Q4	$11.6M	Buy	+52,500	New	+$8.49M	3.72%	10

Harvest Management's CDTX Position: Q1 2026 in Review

Harvest Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 52,500 shares — an estimated $11.6M sold.

Harvest Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $11.6M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Harvest Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Harvest Management sold 52,500 Cidara Therapeutics shares in Q1 2026, an estimated $11.6M.
Harvest Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Harvest Management's Cidara Therapeutics position peaked at $11.6M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Harvest Management's 13F filing for Q1 2026, filed 15 May 2026.